Edition:
India

Taro Pharmaceutical Industries Ltd (TARO.N)

TARO.N on New York Stock Exchange

100.13USD
20 Feb 2018
Change (% chg)

$-1.47 (-1.45%)
Prev Close
$101.60
Open
$100.85
Day's High
$100.85
Day's Low
$98.80
Volume
10,898
Avg. Vol
37,277
52-wk High
$128.25
52-wk Low
$93.59

Latest Key Developments (Source: Significant Developments)

Taro Pharmaceutical quarterly earnings per share $1.30
Wednesday, 8 Nov 2017 

Nov 7 (Reuters) - Taro Pharmaceutical Industries Ltd :Quarterly earnings per share $1.30.Quarterly sales $169.9 million.Taro Pharmaceutical Industries Ltd-qtrly ‍shr $1.30​.  Full Article

Taro announces joining of CEO
Saturday, 2 Sep 2017 

Sept 2 (Reuters) - Taro Pharmaceutical Industries Ltd :Taro announces joining of CEO.Taro Pharmaceutical Industries Ltd - ‍ Uday Baldota has joined company as its chief executive officer ("CEO") effective August 28, 2017​.Says Uday bBaldota appointed CEO.Taro Pharmaceutical Industries Ltd - Baldota replaces mr. Abhay Gandhi, who served in role of interim chief executive officer since January 1, 2017.Taro Pharmaceutical Industries Ltd - Gandhi will continue in his role as vice chairman of Taro board and as CEO of Sun Pharma North America operations​.  Full Article

Taro reports quarterly net income per ordinary share $1.35
Wednesday, 9 Aug 2017 

Aug 9 (Reuters) - Taro Pharmaceutical Industries Ltd -:Taro provides results for quarter ended June 2017.Quarterly sales $161.3 million.Qtrly net income per ordinary share $1.35.  Full Article

Bellus Health to sell subsidiary Thallion Pharmaceuticals to Taro Pharmaceuticals
Friday, 17 Mar 2017 

Bellus Health Inc : Press release - Bellus Health announces the sale of subsidiary Thallion Pharmaceuticals to Taro Pharmaceuticals . Bellus Health Inc - deal for total consideration of CA$2.7 million . Bellus Health Inc- in addition will receive a portion of certain post-approval revenues related to shigamab program .Bellus Health Inc - "upfront proceeds from this transaction also meaningfully extend our cash runway to Q4 2018".  Full Article

Taro posts quarterly sales of $220.4 million
Friday, 10 Feb 2017 

Taro Pharmaceutical Industries Ltd : Taro provides results for December 31, 2016 . Quarterly sales $220.4 million .Taro Pharmaceutical Industries Ltd qtrly net income per ordinary share from continuing operations attributable to taro $3.42.  Full Article

Taro appoints new chief financial officer
Tuesday, 4 Oct 2016 

Taro Pharmaceutical Industries Ltd : Taro appoints new chief financial officer .Appointment of Mariano Balaguer as vice president, CFO and chief accounting officer, effective today.  Full Article

Taro posts qtrly earnings per share $2.59
Thursday, 11 Aug 2016 

Taro Pharmaceutical Industries Ltd : Taro provides results for quarter ended June 2016 . Quarterly sales $233.8 million .Quarterly earnings per share $2.59.  Full Article

Taro Pharma CEO Kal Sundaram to return to Sun Pharma headquarters by the end of 2016
Thursday, 7 Jul 2016 

Taro Pharmaceutical Industries Ltd : Taro ceo Kal Sundaram to return to Sun Pharma headquarters by the end of 2016 . Sundaram informed taro's board of his intention to step down as ceo by end of current calendar year .Board will conduct a formal process to appoint a ceo for taro.  Full Article

Amarin appoints Michael Kalb chief financial officer
Thursday, 30 Jun 2016 

Amarin Corporation Plc : Amarin appoints Michael Kalb chief financial officer .Kalb joins Amarin from Taro Pharmaceutical Industries Ltd.  Full Article

Taro pharmaceutical industries Q4 shr $2.68
Friday, 27 May 2016 

Taro Pharmaceutical Industries Ltd : Qtrly net sales of $265.1 million, increased $20.9 million, or 8.6%, on relatively flat volumes . Taro provides results for year ended march 31, 2016 . Q4 earnings per share $2.68 .Q4 sales rose 8.6 percent to $265.1 million.  Full Article

BRIEF-Taro Pharmaceutical Industries Posts Q3 Earnings Per Share $0.45

* ‍EXCLUDING IMPACT OF ONE-TIME TAX RE-MEASUREMENT, EARNINGS PER SHARE FOR QUARTER WOULD BE $1.37​ Source text for Eikon: Further company coverage: